137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1)
| العنوان: | 137TiP A phase III study of alpelisib and fulvestrant for hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) progressing on or after aromatase inhibitor (AI) therapy (SOLAR-1) |
|---|---|
| المؤلفون: | H. Iwata, G. Rubovszky, S. Loibl, E. Ciruelos, M. Campone, D. Juric, H. Rugo, I. Mayer, P.F. Conte, B. Kaufman, K. Inoue, H. Tesch, Y-S. Li, I.D. Mingorance, L. Ryvo, H. Iwase, A-S. Longin, D. Mills, C. Wilke, F. André |
| المصدر: | Annals of Oncology. 27 |
| بيانات النشر: | Elsevier BV, 2016. |
| سنة النشر: | 2016 |
| مصطلحات موضوعية: | Oncology, Hematology |
| تدمد: | 1569-8041 0923-7534 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::59e5294d8a043bfd25604a3ead91585a https://doi.org/10.1093/annonc/mdw577.020 |
| رقم الأكسشن: | edsair.doi...........59e5294d8a043bfd25604a3ead91585a |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 15698041 09237534 |
|---|